InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Zdanowski Michael, Chief Technology Officer. Director active across 1 company, notably Talaris Therapeutics, Inc.. In total, 2 disclosures have been published. History available since 31 December 2021. The latest transaction was disclosed on 10 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Zdanowski Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
120,000 shares0Common StockSEC:0000899243-22-030933:0
1,470 shares@ US$13.0050.0% of flowCommon StockSEC:0000899243-22-004200:0
2 of 2 declarations
About Zdanowski Michael
Michael Zdanowski is Chief Technology Officer at Talaris Therapeutics, Inc. He is responsible for the technological direction of the company, overseeing the development and implementation of innovative solutions. His technical expertise is crucial for advancing the organization's projects.
